Davita Healthcare Partners Inc. (DVA): Robert J Margolis , Co-Chairman of the Board of Davita Healthcare Partners Inc. sold 31,400 shares on Jun 3, 2015. The Insider selling transaction was disclosed on Jun 5, 2015 to the Securities and Exchange Commission. The shares were sold at $83.41 per share for a total value of $2,618,460.50.

Company has disclosed other insider transaction to SEC, The Securities and Exchange Commission has divulged that Staffieri Michael David, officer (COO, Kidney Care) of Davita Healthcare Partners Inc., had unloaded 9,050 shares at an average price of $84.07 in a transaction dated on May 28, 2015. The total value of the transaction was worth $760,834. Shares of DaVita healthCare Partners Inc. (NYSE:DVA) ended Thursday session in red amid volatile trading. The shares closed down 1.36 points or 1.62% at $82.6 with 855,383 shares getting traded. Post opening the session at $83.63, the shares hit an intraday low of $82.45 and an intraday high of $83.93 and the price vacillated in this range throughout the day. The company has a market cap of $17,754 million and the number of outstanding shares has been calculated to be 214,941,000 shares. The 52-week high of DaVita healthCare Partners Inc. (NYSE:DVA) is $85.17 and the 52-week low is $69.83.

2.76% of the shares are held by the company Insiders, 83.6% of the shares are held by the institutions. Company shares has an average 3 month share volume of 1,097,360 and an average 10 day volume is recorded to be 755,343 The company has received recommendation from many analysts. 5 analysts have rated the company as a strong buy. The shares has been rated as hold from 7 Wall Street Analysts. 1 analysts have suggested buy for the company. Underperform rating was given by 1 analyst.

DaVita HealthCare Partners Inc., formerly DaVita Inc., is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). As of December 31, 2011, the Company provided dialysis and administrative services through a network of 1,809 outpatient dialysis centers located in the United States throughout 43 states and the District of Columbia, serving a total of approximately 142,000 patients. It also provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services throughout the United States. In July 2013, DaVita, a division of DaVita HealthCare Partners Inc announced the acquisition of the dialysis operations of Malaysia’s Caring Dialysis Centre Group (CDC Group) by DVA (Malaysia) Sdn Bhd.

...